Meeting
2020 ASCO Virtual Scientific Program
Pre-transplant molecular minimal residual disease (MMRD) is associated with inferior outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Authors
Muhammad Husnain
University of Miami/Sylvester Cancer Center, Miami, FL
Muhammad Husnain , Krishna Komanduri , Jeremy Ramdial , Lazaros J. Lekakis , Trent Peng Wang , Mark Goodman , Denise L. Pereira , Amer Beitinjaneh , Douglas Carollo , Robert Ali , Yaqub Nadeem Mohammed , Junaid Arshad , Diana Byrnes , Eduardo Edelman Saul , Luis E. Aguirre , Antonio Martin Jimenez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Allogenic Stem Cell Transplantation
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7547)
DOI
10.1200/JCO.2020.38.15_suppl.7547
Abstract #
7547
Poster Bd #
320
Abstract Disclosures
Similar Posters
First Author: Kenneth Joel Bloom
Poster
2018 ASCO Annual Meeting
Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients.
First Author: Tapan M. Kadia
Poster
2023 ASCO Annual Meeting
Clinical and molecular characteristics of patients with AML with an exceptional response to ivosidenib.
First Author: Justin M. Watts
Poster
2022 ASCO Annual Meeting
Mutational landscape and clinical characterization of over 17,000 patients with myeloid malignancies using real-world data.
First Author: Taylor J. Jensen